Evidence map›Paper›PMID 34911784›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2023

Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use.

Marco Chiumente, Melania Rivano, Debora Severino, Sara Bertoli, Anna Rita Gasbarro, Rossella Santeramo, Alessandra Pasqualini, Riccardo Provasi, Daniele Mengato, Angelo Claudio Palozzo

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco ChiumenteScientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy.
Melania RivanoClinical Oncology Pharmacy, Azienda Ospedaliera Brotzu, Cagliari, Italy melania.rivano@gmail.com.ORCID 0000-0002-8541-539X
Debora SeverinoHospital Pharmacy Department, Ausl Modena, Modena, Italy.
Sara BertoliDepartment of Pharmacy, IRCCS National Cancer Institute, Milano, Lombardia, Italy.
Anna Rita GasbarroHospital Pharmacy Department, University Hospital Policlinico, Bari, Italy.
Rossella SanteramoHospital Pharmacy Department, University Hospital Policlinico, Bari, Italy.
Alessandra PasqualiniHospital Pharmacy Department, S.Chiara Hospital, Trento, Italy.
Riccardo ProvasiAzienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy.
Daniele MengatoHospital Pharmacy Department, Azienda Ospedale - Università of Padova, Padova, Italy.ORCID 0000-0003-1374-1505
Angelo Claudio PalozzoPresidency, SIFaCT President, Italian Society for Clinical Pharmacy and Therapy, Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsPharmacy Service, HospitalDrug CompoundingAntineoplastic Agentsantineoplastic agentsdrug compoundingeducationhospitalpharmaceutical preparationspharmacypharmacy service

Identifiers

PMID34911784
PMCPMC10086698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.